InvestorsHub Logo
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Re: None

Tuesday, 09/20/2016 12:52:20 PM

Tuesday, September 20, 2016 12:52:20 PM

Post# of 6033
Heat Biologics submits updates from phase 1/2 trial of HS-110 + Opdivo to World Congress on Lung Cancer according to Biopharm Insight sources
http://charts.stocktwits.com/production/original_62994198.?1474389778

IASLC 17TH WORLD CONFERENCE ON LUNG CANCER
December 4 - 7 2016 | Vienna, Austria |
https://www.iaslc.org/events/iaslc-17th-world-conference-lung-cancer
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NHWK News